Keyword Suggestion
Domain Informations
Icosavax.com lookup results from whois.comlaude.com server:
- Domain created: 2017-08-18T19:55:55Z
- Domain updated: 2024-12-25T05:21:37Z
- Domain expires: 2026-08-18T19:55:55Z 0 Years, 252 Days left
- Website age: 8 Years, 112 Days
- Registrar Domain ID: 2154871261_DOMAIN_COM-VRSN
- Registrar Url: http://www.comlaude.com
- Registrar WHOIS Server: whois.comlaude.com
- Registrar Abuse Contact Email: [email protected]
- Registrar Abuse Contact Phone: +442074218250
- Name server:
- DNS1.COMLAUDE-DNS.COM
- DNS2.COMLAUDE-DNS.NET
- DNS3.COMLAUDE-DNS.CO.UK
- DNS4.COMLAUDE-DNS.EU
Network
- inetnum : 15.196.0.0 - 15.200.255.255
- name : AT-88-Z
- handle : NET-15-196-0-0-1
- status : Direct Allocation
- created : 2011-12-08
- changed : 2024-01-24
- desc : -----BEGIN CERTIFICATE-----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-----END CERTIFICATE-----,All abuse reports MUST include:,* src IP,* dest IP (your IP),* dest port,* Accurate date/timestamp and timezone of activity,* Intensity/frequency (short log extracts),* Your contact details (phone and email) Without these we will be unable to identify the correct owner of the IP address at that point in time.
Owner
- organization : Amazon Technologies Inc.
- handle : AT-88-Z
- address : Array,Seattle,WA,98109,US
Abuse
- handle : AEA8-ARIN
- name : Amazon EC2 Abuse
- phone : +1-206-555-0000
- email : [email protected]
Technical support
- handle : ANO24-ARIN
- name : Amazon EC2 Network Operations
- phone : +1-206-555-0000
- email : [email protected]
| Domain Provider | Number Of Domains |
|---|---|
| godaddy.com | 286730 |
| namecheap.com | 101387 |
| networksolutions.com | 69118 |
| tucows.com | 52617 |
| publicdomainregistry.com | 39120 |
| whois.godaddy.com | 32793 |
| enomdomains.com | 23825 |
| namesilo.com | 21429 |
| domains.google.com | 21384 |
| cloudflare.com | 20573 |
| gmo.jp | 18110 |
| name.com | 17601 |
| fastdomain.com | 14708 |
| register.com | 13495 |
| net.cn | 12481 |
| ionos.com | 12416 |
| ovh.com | 12416 |
| gandi.net | 12305 |
| registrar.amazon.com | 12111 |
Host Informations
- IP address: 15.197.225.128
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
Site Inspections
Port Scanner (IP: 15.197.225.128)
Spam Check (IP: 15.197.225.128)
Email address with icosavax.com
Recent Searched Sites
› 86zw.co (4 seconds ago) / US
› Waveinvoker.newgrounds.com (11 seconds ago) / CA
› Mttp.de (7 seconds ago) / DE
› Munjaon.co.kr (3 seconds ago) / KR
› Eu.auth.pagonxt.com (17 seconds ago) / US
› Precisionlandscapingandlawncare.com (1 seconds ago) / US
› Android-file-transfer.macupdate.com (14 seconds ago) / US
› Saladapg.com (3 seconds ago) / US
› Info.figshare.com (2 seconds ago) / US
› Athens-florists.flowerpetal.com (8 seconds ago) / US
› Buildmyride.com (4 seconds ago) / US
› Muslimhands.org.uk (1 seconds ago) / US
› Simple-internetmarketing.nl (2 seconds ago) / NL
› Hotel-juffer.visitorapp.co (1 seconds ago) / DE
› Yublog.net (5 seconds ago) / JP
› Gom-saver.en.aptoide.com (6 seconds ago) / US
› Fanhao111.site (3 seconds ago) / US
› 95c.ru (6 seconds ago) / RU
› Sugardaddie.com (18 seconds ago) / US
› Icosavax.com (1 seconds ago) / US
Websites Listing
We found Websites Listing below when search with icosavax.com on Search Engine
Icosavax - Email & Phone of top management contacts
Icosavax - email id & phone of top management contacts like Founder, CEO, CFO, CMO, CTO, Marketing or HR or Finance head & all company details. ☰ Pricing; Custom Data; Phone Number Finder; Contact; TRY CONTACT FINDER CUSTOM . Icosavax - Email & Phone of top management contacts. Icosavax. Icosavax is a Biotechnology company and has …
Easyleadz.comIcosavax Inc. (ICVX): Don’t ignore this Blaring Warning ...
2022-03-28 · At the end of the latest market close, Icosavax Inc. (ICVX) was valued at $12.44. In that particular session, Stock kicked-off at the price of $7.89 while reaching the peak value of $7.89 and lowest value recorded on the day was $4.20. The stock current value is $4.41.Recently in News on March 25, 2
Investchronicle.comIcosavax - Crunchbase Company Profile & Funding
Contact Email [email protected]; Icosavax is a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening respiratory diseases. Icosavax’s VLP platform technology is designed to enable multivalent, particle-based display of complex viral antigens, …
Crunchbase.comIcosavax posts COVID-19 vaccine data ‘below our ...
2022-03-25 · Seattle-based vaccine company Icosavax posted disappointing clinical data today for its experimental COVID-19 vaccine, sending its stock into a dive. Icosavax went public last June in an IPO that…
Geekwire.comIcosavax Shares Crater as COVID-19 Vaccine Disappoints ...
2022-03-25 · Icosavax was established in 2017 based on VLP technology from the Institute for Protein Design at the University of Washington. In its January 7 pipeline update , the company noted it had exercised its option for a non-exclusive patent license granted by the University of Washington and the Department of Health and Human Services (HHS) for use with its VLP …
Biospace.comIcosavax, Inc. | LinkedIn
Icosavax, Inc. | 1,341 followers on LinkedIn. Computationally designed VLP vaccine development to reduce serious infectious diseases, including RSV. | Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs and reduce healthcare costs. The company was founded on breakthrough computationally …
Ca.linkedin.comWhy Icosavax's Shares Are Trading Lower Today | Markets ...
2022-03-25 · Icosavax will share interim data from the lead RSV program, IVX-121, in 2Q 2022, ... EMAIL. COPY LINK. Icosavax NewsMORE. Why Icosavax's Shares Are Trading Lower Today. Benzinga 6m. Icosavax posts ...
Markets.businessinsider.comIcosavax – IVX-411
2020-11-03 · Status: Icosavax said October 30 said it had launched its COVID-19 vaccine program. UW researchers and their collaboration partners published preclinical data in the journal Cell showing that IVX ...
Genengnews.comIcosavax Shares Crater as COVID-19 Vaccine Disappoints ...
2022-03-25 · Icosavax’s VLP platform technology allows for multivalent, particle-based display of complex viral antigens. This is believed to induce broad, robust and durable protection against which viruses are targeted. In addition to vaccines for COVID-19, RSV and hMPV, it has an emerging program in influenza. Icosavax was established in 2017 based on VLP technology …
Pharmalive.comIcosavax, Inc. hiring Senior Scientist, Upstream Process ...
Icosavax’s VLP platform technology is designed to enable multivalent, particle-based display of complex viral antigens, which it believes will induce broad, robust, and durable protection ...
Linkedin.comIcosavax Announces Closing of Initial Public Offering and ...
2021-08-02 · Icosavax exclusively licensed the VLP technology for use in several fields, including RSV and hMPV, from the University of Washington. For SARS-CoV-2, Icosavax has a non-exclusive, worldwide (excluding South Korea) license from the University of Washington that will convert to an exclusive license in North America and Europe in 2025. Icosavax is located in …
Ca.finance.yahoo.comSeattle-based Icosavax, which is developing COVID-19 ...
2021-07-07 · Seattle-based Icosavax has filed to go public via an IPO, just four years after it launched out of the University of Washington. The company, a spin-out from the UW's Institute for Protein Design…
Geekwire.comIcosavax, Inc. (Form: 8-K, Received: 01/07/2022 08:42:45)
Item 2.02 Results of Operations and Financial Condition. On January 7, 2022, Icosavax, Inc. issued a press release with a general company update which included its …
Marketwatch.comIcosavax, Inc. hiring Director of Regulatory Affairs in ...
Icosavax, Inc. (NASDAQ: ICVX) is a publicly traded biopharmaceutical company leveraging its innovative VLP platform technology to develop vaccines against infectious diseases, with an initial ...
Linkedin.com@michaelzlin | Twitter
2022-03-25
Twitter.comIcosavax Appoints Dr. John Shiver to Board of Directors
2022-01-05 · About Icosavax Icosavax is a biopharmaceutical company leveraging its innovative VLP platform technology to develop vaccines against infectious diseases, with an initial focus on life-threatening ...
Finance.yahoo.comIcosavax to Participate in Upcoming Investor Conferences ...
2021-11-11 · Icosavax exclusively licensed the VLP technology for use in several fields, including RSV and hMPV, from the University of Washington. For SARS-CoV-2, Icosavax has a non-exclusive, worldwide (excluding South Korea) license from the University of Washington that will convert to an exclusive license in North America and Europe in 2025. Icosavax is located in …
Stockhouse.com@michaelzlin | Twitter
2022-03-25
Twitter.comIcosavax Provides Corporate Update and Anticipated ...
2022-01-07 · Icosavax's VLP platform technology is designed to enable multivalent, particle-based display of complex viral antigens, which it believes will induce broad, robust, and durable protection against ...
Benzinga.comIcosavax Reports Third Quarter 2021 Financial Results and ...
2021-11-15 · Icosavax currently expects its cash balance to be sufficient to fund operations through at least 2024. Research and development (R&D) expenses for the three months ended September 30, 2021 were ...
Benzinga.com
Domains Expiration Date Updated
| Site | Provider | Expiration Date |
|---|---|---|
| m-ape.com | west.cn | -2 Years, -302 Days |
| mbzmfg.com | instra.com | 2 Years, 34 Days |
| tgspliderlik.com | turhost.com | -3 Years, -238 Days |
| france-forfait.com | ovh.com | -3 Years, -265 Days |
| academyclinics.com | register.com | -2 Years, -324 Days |
| replusbureau.com | ukraine.com.ua | -2 Years, -339 Days |
| valentinogress.com | tucows.com | -3 Years, -96 Days |
| pjgglaw.com | gandi.net | -1 Years, -268 Days |
| rehabfamily.com | nic.ru | -3 Years, -284 Days |
| unlock-zone.com | wildwestdomains.com | -3 Years, -220 Days |